WellPoint ‘too cheap to ignore’
Miscues by WellPoint Inc.’s executives have, over the past year, depressed the health insurer’s stock price nearly 20 percent. That’s the upshot of analyst opinions gathered by Barron’s magazine in a March 15 article.